Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis

Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis

Leslie Citrome,1 Mariacristina Castelli,2 Masami Hasebe,3 Takaaki Terahara,3 Justin Faden,4 Marina Komaroff2 1Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA; 2Product Development, Noven Pharmaceuticals, Inc, Jersey City, NJ, USA; 3Hisamitsu Pharmaceutic...

Full description

Bibliographic Details
Main Authors: Citrome L, Castelli M, Hasebe M, Terahara T, Faden J, Komaroff M
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
asenapine
transdermal
patch
schizophrenia
positive and negative syndrome scale
five-factor
Online Access:https://www.dovepress.com/efficacy-of-hp-3070-a-once-daily-asenapine-transdermal-system-in-the-t-peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/efficacy-of-hp-3070-a-once-daily-asenapine-transdermal-system-in-the-t-peer-reviewed-fulltext-article-NDT

Similar Items